Estrone

IHT HOTEL REVENUE CONTINUES TO GROW

Retrieved on: 
Monday, April 8, 2024

IHT hotel operations were strong in the Fiscal Year ended January 31, 2024, and are contributing to a solid start in the current 2025 Fiscal First Quarter, with both the Tucson Hotel and Albuquerque Hotel achieving record results for the combined months of February and March, of the current Fiscal Year.

Key Points: 
  • IHT hotel operations were strong in the Fiscal Year ended January 31, 2024, and are contributing to a solid start in the current 2025 Fiscal First Quarter, with both the Tucson Hotel and Albuquerque Hotel achieving record results for the combined months of February and March, of the current Fiscal Year.
  • These are all positive signs for InnSuites, as progress continues while the Travel Industry, and InnSuites Hospitality Trust (IHT) specifically, continue to grow and thrive.
  • IHT holds convertible bonds and warrants that, when fully exercised, could result in IHT holding an approximate 20% or more ownership stake in UniGen.
  • IHT management believes that due to real estate held on the books of IHT at book values believed to be significantly below current market value and due to the high clean energy diversification profit potential ahead, the IHT future looks bright.

Solutions for Testing Wireless, IP, Fiber Optics, Analog, and TDM Networks

Retrieved on: 
Monday, January 22, 2024

“GL Communications Inc. is a leading test and measurement equipment manufacturer for Wireless, IP, Fiber Optic, Analog and TDM networks.

Key Points: 
  • “GL Communications Inc. is a leading test and measurement equipment manufacturer for Wireless, IP, Fiber Optic, Analog and TDM networks.
  • GL also offers consulting services to design, implement, verify, and inspect communications systems including wireless, IP, satellite, fiber optic, digital, and microwave networks.
  • GL offers multi-functional Ethernet testers to test individual devices such as cables, switches, routers, as well as end-to-end Ethernet/IP networks.
  • The test tools operate at wirespeed (1/10/25/40/50/100 Gbps) and offer bit error rate testing, RFC 2544, ITU-T Y.1564 and RFC 6349 based TCP testing.

IHT DECLARES 54TH CONSECUTIVE ANNUAL DIVIDEND AS REVENUES CONTINUE TO CLIMB WITH RECORD DECEMBER

Retrieved on: 
Monday, January 8, 2024

Phoenix, AZ, Jan. 08, 2024 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) On January 5, 2024, the Board of Trustees of InnSuites Hospitality Trust (NYSE Am: IHT), announced a semi-annual dividend of $0.01 per share payable on February 5, 2024, to shareholders of record as of January 22, 2024, extending an uninterrupted continuous 54-year history of annual dividends.

Key Points: 
  • Phoenix, AZ, Jan. 08, 2024 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) On January 5, 2024, the Board of Trustees of InnSuites Hospitality Trust (NYSE Am: IHT), announced a semi-annual dividend of $0.01 per share payable on February 5, 2024, to shareholders of record as of January 22, 2024, extending an uninterrupted continuous 54-year history of annual dividends.
  • InnSuites hotel operations revenue continues to grow, with the highest combined hotel revenue total ever in December for IHT hotels at $524,219.
  • The UniGen diversified efficient clean energy investment continues to progress, while seeking additional funding.

IHT THIRD FISCAL QUARTER REVENUES INCREASE 7%

Retrieved on: 
Thursday, December 7, 2023

Phoenix, AZ, Dec. 07, 2023 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) reported a continuation of improved results for the Third Quarter of Fiscal 2024, (August 1, 2023, to October 31, 2023), as Total Revenues increased to $1,824,499, which is an increase of 7%, compared to the prior year Fiscal Third Quarter of $1,704,612.

Key Points: 
  • Phoenix, AZ, Dec. 07, 2023 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) reported a continuation of improved results for the Third Quarter of Fiscal 2024, (August 1, 2023, to October 31, 2023), as Total Revenues increased to $1,824,499, which is an increase of 7%, compared to the prior year Fiscal Third Quarter of $1,704,612.
  • The First Three Quarters of Fiscal 2024, (February 1, 2023, to October 31, 2023), remain strong, with Total Revenues up $211,769, at $5,751,583, up over 4% compared to the First Three Quarters of Fiscal 2023 (February 1, 2022, to October 31, 2022).
  • This represents the eighth consecutive Profitable Quarter dating back to Fourth Fiscal Quarter 2022 (November 1, 2021, through January 31, 2022).
  • IHT holds stock, convertible bonds, and warrants that, when fully converted/exercised, could result in IHT holding up to an approximate 25% ownership stake in UniGen.

T3 E3 Signal Analyzer for Channelized and Unchannelized Applications

Retrieved on: 
Wednesday, October 18, 2023

GL's T3 E3 Analyzer is a versatile tool that handles signaling, voice, and data in full T3 (DS3) or E3 data streams.

Key Points: 
  • GL's T3 E3 Analyzer is a versatile tool that handles signaling, voice, and data in full T3 (DS3) or E3 data streams.
  • This analyzer is equipped for both Unchannelized (Unstructured) and Channelized (Structured) T3 E3 Traffic,” said Vijay Kulkarni, CEO of GL Communications.
  • GL also offers T3 E3 probe and rack-mount variants, combining the USB-based T3 E3 Analyzer hardware unit with a Single Board Computer pre-installed with all software and licenses.
  • The T3 E3 hardware platform with associated T1 E1 Send Receive Server and Channelized T3 analyzer software can transmit T1 E1 frames over T3 E3 lines and capture, record, and monitor multiple T1 or E1 channels over Channelized T3 or E3 links.

IHT FIRST FISCAL HALF REVENUES INCREASE

Retrieved on: 
Thursday, September 14, 2023

Phoenix, AZ, Sept. 14, 2023 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) reported a continuation of improved results in the First Fiscal Half of 2024, (February 1, 2023, to July 31, 2023), with Total Revenues up $91,882, at $3,927,084.

Key Points: 
  • Phoenix, AZ, Sept. 14, 2023 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) reported a continuation of improved results in the First Fiscal Half of 2024, (February 1, 2023, to July 31, 2023), with Total Revenues up $91,882, at $3,927,084.
  • Consolidated Net Income before non-cash depreciation expense was $866,611 for the 2024 First Fiscal Half ended July 31, 2023 (February 1, 2023, through July 31, 2023).
  • Net Income Attributable to Controlling Interests for the First Fiscal Half was $245,661.
  • IHT holds stock, convertible bonds, and warrants that, when fully converted/exercised, could result in IHT holding up to an approximate 25% ownership stake in UniGen.

IHT DECLARES 53RD CONSECUTIVE ANNUAL DIVIDEND; ANNUAL PROXY FILED

Retrieved on: 
Wednesday, July 12, 2023

InnSuites hotel operations continue strong, while the investment in UniGen’s diversified efficient clean energy innovation continues to progress.

Key Points: 
  • InnSuites hotel operations continue strong, while the investment in UniGen’s diversified efficient clean energy innovation continues to progress.
  • IHT filed its Fiscal 2023 Annual Report and Proxy on July 9th.
  • IHT holds stock, convertible bonds, and warrants that, when fully converted/exercised, could result in IHT holding an approximate 25% ownership stake in UniGen.
  • In management’s opinion IHT stock continues to be undervalued, with IHT extending its stock buyback program.”

IHT Q1 PROFIT UP 25%

Retrieved on: 
Wednesday, June 14, 2023

Total Trust Equity increased to $4,017,911 at the end of Fiscal First Quarter 2024, up approximately 9%, or $335,766.

Key Points: 
  • Total Trust Equity increased to $4,017,911 at the end of Fiscal First Quarter 2024, up approximately 9%, or $335,766.
  • InnSuites Hospitality Trust (IHT), in late 2019, made a diversification investment in new development privately held UniGen Power, Inc. (UniGen), developing a high risk, high profit potential, efficient clean electricity energy generation innovation.
  • IHT holds stock, convertible bonds, and warrants that, when fully converted/exercised, could result in IHT holding an approximate 25% ownership stake in UniGen.
  • IHT may participate in the upcoming round of capital raising through the exercise of existing warrants, which may or may not result in further increase of IHT fully diluted ownership.

IHT INCOME DOUBLES

Retrieved on: 
Tuesday, May 2, 2023

Earnings Per Share based on this Net Income Attributable to Controlling Interest amount was $0.06, also more than doubling, up $0.03 from the prior year of $0.03.

Key Points: 
  • Earnings Per Share based on this Net Income Attributable to Controlling Interest amount was $0.06, also more than doubling, up $0.03 from the prior year of $0.03.
  • Consolidated Net Income before non-cash depreciation expense was $1,439,437 for the Fiscal Year ended January 31, 2023.
  • These are all positive signs for InnSuites, as progress continues heading in the right direction as the Travel Industry, and InnSuites Hospitality Trust (IHT) specifically, continue to rebound and thrive.
  • IHT holds convertible bonds and warrants that, when fully exercised, could result in IHT holding an approximate 25% ownership stake in UniGen.

Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptom

Retrieved on: 
Thursday, January 26, 2023

SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the publication of data from a Phase 1 trial evaluating the pharmacokinetics of DARE-HRT1, an investigational intravaginal ring (IVR) designed to deliver bio-identical 17β-estradiol and bio-identical progesterone continuously over a 28-day period as part of a hormone therapy regimen, in the journal Menopause, which is the journal of the North American Menopause Society. Daré previously reported positive topline results from this study, as well as from a subsequent Phase 1 / 2 clinical trial of DARE-HRT1. The journal article entitled “Evaluation of 28-Day Estradiol and Progesterone Vaginal Rings in a Phase 1 Clinical Pharmacokinetic Study” is available at the Menopause journal’s website in the Latest Articles section.

Key Points: 
  • Daré previously reported positive topline results from this study, as well as from a subsequent Phase 1 / 2 clinical trial of DARE-HRT1.
  • Hormone therapy is used to treat the vasomotor symptoms (VMS) and genitourinary syndrome associated with menopause.
  • DARE-HRT1 has the potential to be the first FDA-approved product to offer vaginal delivery of combination bio-identical estradiol and bio-identical progesterone hormone therapy in a convenient monthly format.
  • Ongoing activities to support progressing directly into a single Phase 3 study to support registration include manufacturing and non-clinical studies to support the IND submission and the planned IND-opening Phase 3 study.